Your browser doesn't support javascript.
loading
Healthcare risk management during the SARS-CoV-2 virus pandemic in the European Union: The guaranteed access to medicines.
Enríquez-Fernández, Silvia; Del Castillo-Rodríguez, Carlos.
Afiliación
  • Enríquez-Fernández S; Department of Galenic Pharmacy and Food Technology, Teaching Unit of History of Pharmacy and Pharmaceutical Legislation, School of Pharmacy, Complutense University of Madrid, Madrid, Spain.
  • Del Castillo-Rodríguez C; Department of Galenic Pharmacy and Food Technology, Teaching Unit of History of Pharmacy and Pharmaceutical Legislation, School of Pharmacy, Complutense University of Madrid, Madrid, Spain.
Int J Risk Saf Med ; 32(2): 77-86, 2021.
Article en En | MEDLINE | ID: mdl-33579877
BACKGROUND: The disease caused by the novel coronavirus SARS-CoV-2 has rapidly spread escalating the situation to an international pandemic. The absence of a vaccine or an efficient treatment with enough scientific evidence against the virus has generated a healthcare crisis of great magnitude. The precautionary principle justifies the selection of the recommended medicines, whose demand has increased dramatically. METHODS: we carried out an analysis of the healthcare risk management and the main measures taken by the state healthcare authorities to a possible shortage of medicines in the most affected countries of the European Union: Spain, France, Italy and Germany. RESULTS: the healthcare risk management in the European Union countries is carried out based on the precautionary principle, as we do not have enough scientific evidence to recommend a specific treatment against the new virus. Some measures aimed to guarantee the access to medicines for the population has been adopted in the most affected countries by the novel coronavirus. CONCLUSIONS: in Spain, Italy and Germany, some rules based on the precautionary principle were pronounced in order to guarantee the supply of medicines, while in France, besides that, the competences of pharmacists in pharmacy offices have been extended to guarantee the access to medicines for the population.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Gestión de Riesgos / Atención a la Salud / Reserva Estratégica / COVID-19 / Tratamiento Farmacológico de COVID-19 / Accesibilidad a los Servicios de Salud Tipo de estudio: Etiology_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Int J Risk Saf Med Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Gestión de Riesgos / Atención a la Salud / Reserva Estratégica / COVID-19 / Tratamiento Farmacológico de COVID-19 / Accesibilidad a los Servicios de Salud Tipo de estudio: Etiology_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Int J Risk Saf Med Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Países Bajos